-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Meridian Bioscience Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Meridian Bioscience Inc Operating Income (Loss) for the quarter ending December 31, 2022 was -$28.1M, a 239% decline year-over-year.
- Meridian Bioscience Inc Operating Income (Loss) for the twelve months ending December 31, 2022 was $5.99M, a 92.4% decline year-over-year.
- Meridian Bioscience Inc annual Operating Income (Loss) for 2022 was $54.4M, a 41.5% decline from 2021.
- Meridian Bioscience Inc annual Operating Income (Loss) for 2021 was $93M, a 51.7% increase from 2020.
- Meridian Bioscience Inc annual Operating Income (Loss) for 2020 was $61.3M, a 87.5% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)